Determine the necessary mass, volume, or concentration for preparing a solution.
for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Room temperature Ships Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 4 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Kolliphor® HS 15, a pH-independent non-ionic surfactant, is an effective solubilizer and emulsifying agent. It is soluble in aqueous media and polar organic solvents however it is not soluble in apolar solvents. Its structure has 12-hydroxystearic acid (lipophilic moiety) and polyethylene glycol (hydrophilic moiety).
Application:
Kolliphor® HS 15 has been used:
in dissolving dexamethasone (DEX) to intraperitoneally inject the mice to test its grip strength to measure the muscle force
in roflumilast preparation to treat rabbits and guinea pigs to study the mechanisms and pharmacological sensitivity of ozone-induced hypertussive responses
to dissolve finerenone for oral application in in vivo-studies
Advantages and Features:
Low histamine release for fewer side-effects
Offers thermal stability, suitable for heat sterilization
Has lower hemolytic activity than other polyoxyethylene-based surfactants
Allows to formulate poorly soluble APIs in oral and parenteral dosage forms
| Pubchem Sid | 504773207 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504773207 |
| Alternate CAS | 61909-81-7、105109-85-1、6284-41-9 |
| PubChem CID | 135327775 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Apr 24, 2026 | K487242 | |
| Certificate of Analysis | Apr 24, 2026 | K487242 | |
| Certificate of Analysis | Apr 24, 2026 | K487242 | |
| Certificate of Analysis | Sep 20, 2025 | K487242 | |
| Certificate of Analysis | Sep 20, 2025 | K487242 | |
| Certificate of Analysis | Sep 20, 2025 | K487242 | |
| Certificate of Analysis | Sep 20, 2025 | K487242 | |
| Certificate of Analysis | Apr 23, 2025 | K487242 | |
| Certificate of Analysis | Apr 23, 2025 | K487242 | |
| Certificate of Analysis | Apr 23, 2025 | K487242 | |
| Certificate of Analysis | Nov 01, 2024 | K487242 | |
| Certificate of Analysis | Nov 01, 2024 | K487242 | |
| Certificate of Analysis | Nov 01, 2024 | K487242 | |
| Certificate of Analysis | Aug 02, 2024 | K487242 | |
| Certificate of Analysis | Aug 02, 2024 | K487242 | |
| Certificate of Analysis | Aug 02, 2024 | K487242 | |
| Certificate of Analysis | Aug 02, 2024 | K487242 | |
| Certificate of Analysis | Mar 14, 2024 | K487242 | |
| Certificate of Analysis | Mar 14, 2024 | K487242 | |
| Certificate of Analysis | Mar 14, 2024 | K487242 | |
| Certificate of Analysis | Jan 23, 2024 | K487242 | |
| Certificate of Analysis | Jan 23, 2024 | K487242 | |
| Certificate of Analysis | Jan 23, 2024 | K487242 | |
| Certificate of Analysis | Jun 21, 2023 | K487242 | |
| Certificate of Analysis | Jun 21, 2023 | K487242 | |
| Certificate of Analysis | Jun 21, 2023 | K487242 | |
| Certificate of Analysis | Jun 21, 2023 | K487242 | |
| Certificate of Analysis | Jun 21, 2023 | K487242 | |
| Certificate of Analysis | Mar 25, 2023 | K487242 | |
| Certificate of Analysis | Mar 25, 2023 | K487242 |
| 1. Jun Li, Yangyang Yang, Xiumin Han, Jing Li, Mengxiao Tian, Wenjing Qi, Huniu An, Chuanchuan Wu, Yao Zhang, Shuai Han, Liping Duan, Weisi Wang, Wenbao Zhang. (2023) Oral Delivery of Anti-Parasitic Agent-Loaded PLGA Nanoparticles: Enhanced Liver Targeting and Improved Therapeutic Effect on Hepatic Alveolar Echinococcosis. International Journal of Nanomedicine, [PMID:37312930] [10.2147/IJN.S397526] |
| 2. Jingwen Luo, Zhiwei Zhang, Yingchun Zeng, Yanming Dong, Lixin Ma. (2021) Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis. CARBOHYDRATE POLYMERS, [PMID:33858569] [10.1016/j.carbpol.2021.117964] |
| 3. Chenglong Li, Shuhao Xu, Xin Li, Huaiyu Su, Can Qian, Yingying Hou, Sanjun Shi. (2025) A Transformable Nanoplatform Precisely Positions Fibroblast-Like Synoviocytes via FAP-α for Improved Rheumatoid Arthritis Therapy. Advanced Healthcare Materials, [PMID:40931560] [10.1002/adhm.202503277] |
| 4. Xin Zhang, Zutong Cui, Wenming Liang, Zihan Zhang, Jianming Sun, Liming Gao, Ming Shi, Zhiwei Liu, Kun Li, Jian Li. (2026) Disrupting the Fortress: A Biomimetic Nano-Dual-Sensitizer Remodels Tumor Microenvironment via Dual HIF-1α Inhibition for Robust Photo-Immunotherapy. ACS Applied Materials & Interfaces, [PMID:] [10.1021/acsami.5c24160] |